Insider buying last 90 days
No open-market insider purchases were filed for SNN in the last 90 days.
From Form 4 filings, dated to when each was filed.
Every SNN insider filing, plotted on the chart in Gekko.Open SNN in Gekko
Smith & Nephew SNATS (SNN) Stock Analysis & Forecast
Sep 28 close
$27.08+0.17 (+0.6%)
Gekko Brief
AI summarySmith & Nephew's shares slid to a new 52-week low this week after the company reported second-quarter revenue of $1.6 billion, short of the $1.64 billion analyst forecast, with underlying revenue growth of 1.6% masking weakness in U.S. orthopaedics and SANTYL. Alongside the miss, the company pressed ahead with product launches, including FDA 510(k) clearance and a first surgical case for its LANDMARK Total Knee System, and the launch of the EVOS PELVIC Plating System at the Orthopedic Trauma Association meeting, both aimed at expanding its orthopaedic and trauma offerings.
The stock closed at $27.08, down against its 50-day average of $29.28 and 200-day average of $31.61, with the 50-day below the 200-day. It sits within its 52-week range, having touched a low of $26.4 against a high of $37.51, and returns over one, three, six and twelve months are negative at -7%, -10.6%, -14.4% and -23.2% respectively. The GekkoIndex reading of 66.8 places it in the Accumulation zone, and the price stands 10.6% below the Gekko Fair Value of $30.30.
No confirmed earnings date is on the calendar for the next stretch, and no insider, Congress or unusual options activity appears in the respective 90-day and 30-day windows. Consensus among four covering firms shows one buy and three hold ratings, with a consensus target of $32.89. Seasonality over the past 5 years shows an average 20-trading-day return of -2.7% from this point in the calendar, rising in 3 of those 5 years.
Written by AI and checked automatically against the figures on this page. Generated Sep 29, 2026 from the data above.
Smith & Nephew SNATS price vs fair value
Close $27.08200-day averageGekko Fair Value $30.30
Smith & Nephew SNATS quick facts
- Market cap
- $11.37B
- P/E ratio
- 18.3
- Forward P/E
- 11.2
- EPS, TTM
- $1.46
- Revenue, TTM
- $6.30B
- Profit margin
- 10.1%
- Dividend yield
- 2.96%
- Beta
- 0.68
- Volume
- 826,472 avg 1.84M
- 1-year return
- −23.2%
- Typical daily move
- ±1.7%
- Typical 20-day move
- ±4.9%
- 50-day average
- $29.28
- 200-day average
- $31.61
- Next earnings
- —
- Shares outstanding
- 418.5M
Smith & Nephew SNATS swing-trade checklist
Smith & Nephew SNATS scores 2 supportive, 1 mixed and 1 headwind across the 4 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
2 supportive1 mixed1 headwind
- Trendheadwind
Below 50 and 200-day
Close $27.08 is below the 50-day ($29.28) and 200-day ($31.61) averages, and the 50-day is below the 200-day.
See the chart - GekkoIndexsupportive
66.8, Accumulation
Reading 66.8 is in the Accumulation zone.
See the GekkoIndex - Fair valuesupportive
10.6% below
Price is 10.6% below Gekko Fair Value (more than 5% below).
See fair value - Smart moneyno data
No data
No insider, Congress or unusual options activity in the window.
See smart money - Earnings riskno data
No data
No confirmed report date on the calendar.
- Seasonalitymixed
−2.7% on average
From this point in the calendar, the next 20 trading days averaged −2.7% over 5 years, rising in 3 of them.
See seasonality
A description of current data, not a recommendation. How this page works
Smith & Nephew SNATS stock chart and price history
Smith & Nephew SNATS closed at $27.08 on Sep 28, 2026, −23.2% over the past year, inside a 52-week range of $26.40 to $37.51.
Close50-day average200-day averageVolume
Use the left and right arrow keys to read daily values.
Performance Breakdown
- 1 month
- −7.0%
- 3 months
- −10.6%
- 6 months
- −14.4%
- 1 year
- −23.2%
The full SNN chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open SNN in Gekko
Follow Smith & Nephew SNATS through every session
Put SNN on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Track SNN in GekkoFree for 7 days. No credit card required.
About Smith & Nephew SNATS
Smith & Nephew SNATS develops, manufactures and sells medical devices and related services used in surgery and wound care, reaching healthcare providers in the United Kingdom, the United States and other markets. It is recognized for products supporting joint replacement, sports medicine procedures and the treatment of wounds ranging from minor injuries to chronic ulcers and burns.
The company organizes its work across three areas: orthopaedics, sports medicine and ENT, and advanced wound management. Its orthopaedics offerings include knee and hip implants along with trauma and extremities devices for stabilizing fractures and correcting deformities. The sports medicine and ENT segment supplies instruments and implants for minimally invasive joint repair, along with visualization and tissue resection tools used during arthroscopic surgery, plus ear, nose and throat products. The wound management segment covers dressings and devices for acute and chronic wounds, along with bioactive and regenerative products such as skin and bone graft substitutes, all sold to hospitals and other healthcare providers.
Smith & Nephew SNATS traces its founding to 1856 and is headquartered in Watford, in the United Kingdom. Its shares trade under the ticker SNN.
- Sector
- Health technology
- Website
- smith-nephew.com
Smith & Nephew SNATS GekkoIndex: the smart money zone
Smith & Nephew SNATS’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 66.8, in the Accumulation zone, up 0.6 points over five sessions.
66.8Accumulation
Up 0.6 points over five sessions.
Reading for Sep 28, 2026
What followed past readings in each zone
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 51 | +0.9% | +0.6% | ||
| Accumulation (current zone) | 219 | −0.1% | +0.3% | ||
| Neutral | 323 | +0.1% | +0.8% | ||
| Distribution | 32 | +0.4% | +2.7% | ||
| Selling | 0 | Not available | |||
Average SNN share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Accumulation readings averaged +2.3% over 20 days. Past behaviour doesn’t guarantee future results.
Accumulation zone: Institutional interest building. About the five zones →
See every daily GekkoIndex reading plotted over the SNN price, zone by zone.Track SNN in Gekko
Is Smith & Nephew SNATS stock overvalued? Gekko Fair Value
Smith & Nephew SNATS trades 10.6% below Gekko Fair Value of $30.30, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what Smith & Nephew SNATS shares are worth, recalculated every trading day.
$30.30
Gekko Fair Value, Sep 26, 2026
10.6% Undervalued
Gekko Fair Value on every chart, with the gap to price updating daily.Open SNN in Gekko
Smith & Nephew SNATS insider and Congress trading
No open-market insider purchases were filed for Smith & Nephew SNATS, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
Congress trades last 90 days
No trades in SNN were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Congress disclosures for SNN, plotted on the chart in Gekko.Open SNN in Gekko
Buybacks
Smith & Nephew SNATS has been buying back its own shares.
- Bought back, quarter ended Jun 27, 2026
- $116.0M
- As a share of market cap
- 1.02%
From company filings.
Hedge funds and billionaires quarter ended Sep 30
0of the funds Gekko tracks hold SNN.
0added0opened0trimmed1sold out
Which funds are on each side, name by name.Unlock in Gekko
Smith & Nephew SNATS stock forecast and analyst price targets
Analysts’ average 12-month price target for Smith & Nephew SNATS is $32.89, +21.5% from the last close, from 4 firms rating the stock in the last 90 days.
$32.89consensus 12-month target, +21.5% from the last close
Now $27.08Avg $32.89
Low $30High $33.77
Each firm’s latest rating in the last 90 days: 4 firms.
Latest analyst actions
| Date | Firm | Target | vs price |
|---|---|---|---|
| Sep 23 | Canaccord Genuity | $30 | +10.8% |
| Sep 21 | BTIG | — | — |
| Aug 31 | BTIG | — | — |
| Aug 20 | Canaccord Genuity | $30 | +10.8% |
| Aug 17 | Canaccord Genuity | $30 | +10.8% |
+0.3%average 20-day move after past Accumulation readings
−2.7%average move over the next 20 trading days in the last 5 years
±1.7%typical daily move, from the 14-day average range
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Smith & Nephew SNATS seasonality: the next 20 trading days
Over the next 20 trading days from Sep 29, Smith & Nephew SNATS averaged −2.7% across the last 5 years, rising in 3 of them.
Next 20 trading days, by year
Average move and hit rate
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | −1.5% | 2 of 5 |
| Next 10 trading days | −3.8% | 1 of 5 |
| Next 15 trading days | −2.1% | 3 of 5 |
| Next 20 trading days | −2.7% | 3 of 5 |
| Next 30 trading days | −3.5% | 2 of 5 |
For scale, SNN’s typical 20-trading-day move in either direction is about 4.9%.
Smith & Nephew SNATS market cap and key statistics
Smith & Nephew SNATS’s market cap is $11.37B, with a P/E ratio of 18.3 and revenue of $6.30B over the last twelve months.
Valuation
- Market cap
- $11.37B
- P/E ratio
- 18.3
- Forward P/E
- 11.2
- EPS, TTM
- $1.46
- Gekko Fair Value
- $30.30
Trading
- Volume
- 826,472
- Avg volume, 20 days
- 1.84M
- 52-week high
- $37.51
- 52-week low
- $26.40
- Shares outstanding
- 418.5M
Financials
- Revenue, TTM
- $6.30B
- Profit margin
- 10.1%
- Return on equity
- 11.8%
- Quarterly earnings growth, YoY
- +5.7%
Risk and income
- Beta
- 0.68
- Typical daily move
- ±1.7%
- Typical 20-day move
- ±4.9%
- Dividend yield
- 2.96%
Smith & Nephew SNATS stock news this week
Coverage of Smith & Nephew SNATS this week reads positive: 7 positive, 0 neutral and 3 negative headlines.
- Smith & Nephew stock faces a Q2 revenue missAD HOC NEWS, Sep 25
- Smith & Nephew SNATS (NYSE:SNN) Reaches New 52-Week Low – Time to Sell?Defense World, Sep 25
- Smith and Nephew stock falls 0.24 percent ahead of the openAD HOC NEWS, Sep 25
- Smith+Nephew Launches the New Evos? Pelvic Plating Systemwww.marketscreener.com, Sep 23
- Natural design. Amplified: Smith+Nephew announces FDA 510(k) clearance and first surgical case of LANDMARK◊ Total Knee SystemOrtho Spine News, Sep 23
- Smith+Nephew launches the new EVOS™ PELVIC Plating SystemGlobeNewswire, Sep 23
Smith & Nephew SNATS stock FAQ
What is Smith & Nephew SNATS’s market cap?
Smith & Nephew SNATS’s market cap is $11.37B at the Sep 28, 2026 close of $27.08, with 418.5M shares outstanding. The shares trade on a P/E ratio of 18.3.
What is the Smith & Nephew SNATS stock forecast?
The consensus analyst 12-month price target for Smith & Nephew SNATS is $32.89, +21.5% from the last close. Of the 4 firms that rated the stock in the last 90 days, 1 rate it a buy, 3 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
Is Smith & Nephew SNATS stock overvalued or undervalued?
On Gekko’s estimate Smith & Nephew SNATS is undervalued: the Sep 28, 2026 close of $27.08 is 10.6% below Gekko Fair Value of $30.30. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
What is Smith & Nephew SNATS’s 52-week high and low?
Smith & Nephew SNATS’s 52-week high is $37.51 and its 52-week low is $26.40; it closed at $27.08 on Sep 28, 2026, −23.2% over the past year. Over the last five years the shares peaked at $38.79 on Sep 9, 2025.
Is Smith & Nephew SNATS stock a buy right now?
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 2 of the 4 items with data read as supportive (gekkoindex and fair value), 1 as mixed (seasonality) and 1 as a headwind (trend). The checklist is a description of current data, not a recommendation.
How this page works
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
See Smith & Nephew SNATS the way Gekko members do
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,380 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.